Shock Wave Therapy Enhances Angiogenesis through VEGFR2 Activation and Recycling

Abstract Although low-energy shock wave (SW) is adopted to treat ischemic diseases because of its pro-angiogenic properties, the underlying mechanism remains unclear. This study is aimed at testing whether SW-induced angiogenesis may be through endothelial vascular endothelial growth factor receptor...

Full description

Bibliographic Details
Main Authors: Tien-Hung Huang, Cheuk-Kwan Sun, Yi-Ling Chen, Ching-Jen Wang, Tsung-Cheng Yin, Mel S Lee, Hon-Kan Yip
Format: Article
Language:English
Published: BMC 2016-12-01
Series:Molecular Medicine
Online Access:http://link.springer.com/article/10.2119/molmed.2016.00108
_version_ 1817976085643526144
author Tien-Hung Huang
Cheuk-Kwan Sun
Yi-Ling Chen
Ching-Jen Wang
Tsung-Cheng Yin
Mel S Lee
Hon-Kan Yip
author_facet Tien-Hung Huang
Cheuk-Kwan Sun
Yi-Ling Chen
Ching-Jen Wang
Tsung-Cheng Yin
Mel S Lee
Hon-Kan Yip
author_sort Tien-Hung Huang
collection DOAJ
description Abstract Although low-energy shock wave (SW) is adopted to treat ischemic diseases because of its pro-angiogenic properties, the underlying mechanism remains unclear. This study is aimed at testing whether SW-induced angiogenesis may be through endothelial vascular endothelial growth factor receptor 2 (VEGFR2) signaling and trafficking. Phosphorylation of VEGFR2-Akt-eNOS axis and production of nitric oxide (NO) were determined in human umbilical vein endothelial cells (HUVECs) treated with SW. Carotid artery in ob/ob mice was treated with SW before evaluation with sprouting assay. Critical limb ischemia was induced in ob/ob mice to evaluate blood flow recovery post-SW treatment. Tube formation and migration assays were also performed with/without SW treatment in the presence/absence of SU5416 (VEGFR2 kinase inhibitor) and siRNA-driven silencing of VEGFR2. Chloroquine was used for disrupting endosome, and Rab11a controlling slow endocytic recycling was silenced with siRNA in vitro. Following SW treatment, augmented ligand-independent phosphorylation in VEGFR2-Akt-eNOS axis and endogenous NO production, increased cellular migration and tube formation and elevated sprouting of carotid artery and blood flow in ischemic limb in ob/ob mice were noted. Moreover, SU5416 and VEGFR2 silencing both inhibited SW-induced angiogenesis. SW-induced angiogenesis, accompanied by increased VEGFR2 protein expression without transcriptional change, was suppressed by chloroquine and Rab11a silencing. We concluded that SW enhanced angiogenesis via ligand-independent activation of VEGFR2 and further prolonged angiogenesis through endosome-to-plasma membrane recycling in endothelial cells.
first_indexed 2024-04-13T21:57:53Z
format Article
id doaj.art-f022f3e0695844748ef54a2a03c62d79
institution Directory Open Access Journal
issn 1076-1551
1528-3658
language English
last_indexed 2024-04-13T21:57:53Z
publishDate 2016-12-01
publisher BMC
record_format Article
series Molecular Medicine
spelling doaj.art-f022f3e0695844748ef54a2a03c62d792022-12-22T02:28:12ZengBMCMolecular Medicine1076-15511528-36582016-12-0122185086210.2119/molmed.2016.00108Shock Wave Therapy Enhances Angiogenesis through VEGFR2 Activation and RecyclingTien-Hung Huang0Cheuk-Kwan Sun1Yi-Ling Chen2Ching-Jen Wang3Tsung-Cheng Yin4Mel S Lee5Hon-Kan Yip6Division of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial HospitalDepartment of Emergency Medicine, E-Da Hospital, I-Shou University School of Medicine for International StudentDivision of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial HospitalCenter for Shockwave Medicine and Tissue Engineering, Kaohsiung Chang Gung Memorial HospitalDepartment of Orthopedic Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineDepartment of Orthopedic Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of MedicineDivision of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial HospitalAbstract Although low-energy shock wave (SW) is adopted to treat ischemic diseases because of its pro-angiogenic properties, the underlying mechanism remains unclear. This study is aimed at testing whether SW-induced angiogenesis may be through endothelial vascular endothelial growth factor receptor 2 (VEGFR2) signaling and trafficking. Phosphorylation of VEGFR2-Akt-eNOS axis and production of nitric oxide (NO) were determined in human umbilical vein endothelial cells (HUVECs) treated with SW. Carotid artery in ob/ob mice was treated with SW before evaluation with sprouting assay. Critical limb ischemia was induced in ob/ob mice to evaluate blood flow recovery post-SW treatment. Tube formation and migration assays were also performed with/without SW treatment in the presence/absence of SU5416 (VEGFR2 kinase inhibitor) and siRNA-driven silencing of VEGFR2. Chloroquine was used for disrupting endosome, and Rab11a controlling slow endocytic recycling was silenced with siRNA in vitro. Following SW treatment, augmented ligand-independent phosphorylation in VEGFR2-Akt-eNOS axis and endogenous NO production, increased cellular migration and tube formation and elevated sprouting of carotid artery and blood flow in ischemic limb in ob/ob mice were noted. Moreover, SU5416 and VEGFR2 silencing both inhibited SW-induced angiogenesis. SW-induced angiogenesis, accompanied by increased VEGFR2 protein expression without transcriptional change, was suppressed by chloroquine and Rab11a silencing. We concluded that SW enhanced angiogenesis via ligand-independent activation of VEGFR2 and further prolonged angiogenesis through endosome-to-plasma membrane recycling in endothelial cells.http://link.springer.com/article/10.2119/molmed.2016.00108
spellingShingle Tien-Hung Huang
Cheuk-Kwan Sun
Yi-Ling Chen
Ching-Jen Wang
Tsung-Cheng Yin
Mel S Lee
Hon-Kan Yip
Shock Wave Therapy Enhances Angiogenesis through VEGFR2 Activation and Recycling
Molecular Medicine
title Shock Wave Therapy Enhances Angiogenesis through VEGFR2 Activation and Recycling
title_full Shock Wave Therapy Enhances Angiogenesis through VEGFR2 Activation and Recycling
title_fullStr Shock Wave Therapy Enhances Angiogenesis through VEGFR2 Activation and Recycling
title_full_unstemmed Shock Wave Therapy Enhances Angiogenesis through VEGFR2 Activation and Recycling
title_short Shock Wave Therapy Enhances Angiogenesis through VEGFR2 Activation and Recycling
title_sort shock wave therapy enhances angiogenesis through vegfr2 activation and recycling
url http://link.springer.com/article/10.2119/molmed.2016.00108
work_keys_str_mv AT tienhunghuang shockwavetherapyenhancesangiogenesisthroughvegfr2activationandrecycling
AT cheukkwansun shockwavetherapyenhancesangiogenesisthroughvegfr2activationandrecycling
AT yilingchen shockwavetherapyenhancesangiogenesisthroughvegfr2activationandrecycling
AT chingjenwang shockwavetherapyenhancesangiogenesisthroughvegfr2activationandrecycling
AT tsungchengyin shockwavetherapyenhancesangiogenesisthroughvegfr2activationandrecycling
AT melslee shockwavetherapyenhancesangiogenesisthroughvegfr2activationandrecycling
AT honkanyip shockwavetherapyenhancesangiogenesisthroughvegfr2activationandrecycling